Literature DB >> 3571184

Subcellular distribution of OM cytochrome b-mediated NADH-semidehydroascorbate reductase activity in rat liver.

H Nishino, A Ito.   

Abstract

Tissue, cellular, and subcellular distributions of OM cytochrome b-mediated NADH-semidehydroascorbate (SDA) reductase activity were investigated in rat. NADH-SDA reductase activity was found in the post-nuclear particulate fractions of liver, kidney, adrenal gland, heart, brain, lung, and spleen of rat. Liver, kidney, and adrenal gland had higher NADH-SDA reductase activity than other tissues, and OM cytochrome b-dependent activity was 60-70% of the total activity. On the other hand, almost all of the reductase activity of heart and brain cells was mediated by OM cytochrome b. The ratio of the OM cytochrome b-mediated activities of NADH-SDA reductase to rotenone-insensitive NADH-cytochrome c reductase varied among these tissues. OM cytochrome b-mediated NADH-SDA reductase and rotenone-insensitive NADH-cytochrome c reductase activities were mainly present in the parenchymal cells of rat liver. The localization of the cytochrome-mediated reductase activities in the outer mitochondrial membrane was confirmed by subfractionation of liver mitochondria. Among the submicrosomal fractions, OM cytochrome b-mediated NADH-SDA reductase activity was highest in the cis-Golgi membrane fraction, in which monoamine oxidase activity was also highest. On the other hand, OM cytochrome b-mediated rotenone-insensitive NADH-cytochrome c reductase activity showed a slightly different distribution pattern from the NADH-SDA reductase activity. Thenoyltrifluoroacetone (TTFA), a metal chelator, effectively inhibited the NADH-SDA reductase activity, though other metal chelators did not affect the activity. TTFA failed to inhibit rotenone-insensitive NADH-cytochrome c reductase activity at the concentration which gave complete inhibition of NADH-SDA reductase activity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3571184     DOI: 10.1093/oxfordjournals.jbchem.a121859

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  7 in total

Review 1.  Metalloproteins containing cytochrome, iron-sulfur, or copper redox centers.

Authors:  Jing Liu; Saumen Chakraborty; Parisa Hosseinzadeh; Yang Yu; Shiliang Tian; Igor Petrik; Ambika Bhagi; Yi Lu
Journal:  Chem Rev       Date:  2014-04-23       Impact factor: 60.622

2.  Ascorbate free-radical reduction by glyoxysomal membranes.

Authors:  M L Bowditch; R P Donaldson
Journal:  Plant Physiol       Date:  1990-10       Impact factor: 8.340

3.  Ascorbate radical levels in human sera and rat plasma intoxicated with paraquat and diquat.

Authors:  K Minakata; O Suzuki; S Saito; N Harada
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

4.  Mitochondria-ros crosstalk in the control of cell death and aging.

Authors:  Saverio Marchi; Carlotta Giorgi; Jan M Suski; Chiara Agnoletto; Angela Bononi; Massimo Bonora; Elena De Marchi; Sonia Missiroli; Simone Patergnani; Federica Poletti; Alessandro Rimessi; Jerzy Duszynski; Mariusz R Wieckowski; Paolo Pinton
Journal:  J Signal Transduct       Date:  2011-11-14

Review 5.  Mitochondria-associated membranes in aging and senescence: structure, function, and dynamics.

Authors:  Justyna Janikiewicz; Jędrzej Szymański; Dominika Malinska; Paulina Patalas-Krawczyk; Bernadeta Michalska; Jerzy Duszyński; Carlotta Giorgi; Massimo Bonora; Agnieszka Dobrzyn; Mariusz R Wieckowski
Journal:  Cell Death Dis       Date:  2018-02-28       Impact factor: 8.469

6.  A novel point mutation in a 3' splice site of the NADH-cytochrome b5 reductase gene results in immunologically undetectable enzyme and impaired NADH-dependent ascorbate regeneration in cultured fibroblasts of a patient with type II hereditary methemoglobinemia.

Authors:  K Shirabe; M T Landi; M Takeshita; G Uziel; E Fedrizzi; N Borgese
Journal:  Am J Hum Genet       Date:  1995-08       Impact factor: 11.025

Review 7.  Cellular and Molecular Mechanisms of Recessive Hereditary Methaemoglobinaemia Type II.

Authors:  Emilio Siendones; Manuel Ballesteros; Plácido Navas
Journal:  J Clin Med       Date:  2018-10-10       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.